↗️ Novo Nordisk (DK:NOVO.B, NVO): The drugmaker said its experimental Wegovy weight-loss pill helped patients lose about as much weight as a weekly injection in a late-stage trial. Plus, it said Ozempic reduced the risk of heart attack, stroke and death by 23% versus a rival drug.